0 XP   0   0   0

Actinogen Medical Ltd
Buy, Hold or Sell?

Let's analyse Actinogen together

PenkeI guess you are interested in Actinogen Medical Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Actinogen Medical Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Actinogen Medical Ltd

I send you an email if I find something interesting about Actinogen Medical Ltd.

Quick analysis of Actinogen (30 sec.)










1. Valuation of Actinogen (5 min.)




Current price per share

A$0.05

2. Growth of Actinogen (5 min.)




Is Actinogen growing?

Current yearPrevious yearGrowGrow %
How rich?$14.2m$11.4m$2.8m19.7%

How much money is Actinogen making?

Current yearPrevious yearGrowGrow %
Making money-$6.2m-$2.5m-$3.6m?
Net Profit Margin-23,169.8%-14,534.5%--

How much money comes from the company's main activities?

3. Financial Health of Actinogen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#792 / 1215

Most Revenue
#733 / 1215

Most Profit
#541 / 1215

Most Efficient
#1157 / 1215


Fundamentals of Actinogen

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Actinogen Medical Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Actinogen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • A Net Profit Margin of -23,169.8% means that $-231.70 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Actinogen Medical Ltd:

  • The MRQ is -23,169.8%. The company is making a huge loss. -2
  • The TTM is -23,169.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-23,169.8%TTM-23,169.8%0.0%
TTM-23,169.8%YOY-14,534.5%-8,635.4%
TTM-23,169.8%5Y-12,601.3%-10,568.6%
5Y-12,601.3%10Y-8,521.8%-4,079.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-23,169.8%-194.7%-22,975.1%
TTM-23,169.8%-272.1%-22,897.7%
YOY-14,534.5%-303.9%-14,230.6%
5Y-12,601.3%-539.0%-12,062.3%
10Y-8,521.8%-661.6%-7,860.2%
1.1.2. Return on Assets

Shows how efficient Actinogen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • -40.8% Return on Assets means that Actinogen generated $-0.41 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Actinogen Medical Ltd:

  • The MRQ is -40.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -40.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.8%TTM-40.8%0.0%
TTM-40.8%YOY-21.4%-19.4%
TTM-40.8%5Y-41.1%+0.3%
5Y-41.1%10Y-39.4%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.8%-12.6%-28.2%
TTM-40.8%-12.6%-28.2%
YOY-21.4%-10.9%-10.5%
5Y-41.1%-15.3%-25.8%
10Y-39.4%-17.7%-21.7%
1.1.3. Return on Equity

Shows how efficient Actinogen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • -43.8% Return on Equity means Actinogen generated $-0.44 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Actinogen Medical Ltd:

  • The MRQ is -43.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -43.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-43.8%TTM-43.8%0.0%
TTM-43.8%YOY-22.6%-21.2%
TTM-43.8%5Y-43.6%-0.2%
5Y-43.6%10Y-43.8%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-43.8%-15.3%-28.5%
TTM-43.8%-15.6%-28.2%
YOY-22.6%-13.2%-9.4%
5Y-43.6%-20.5%-23.1%
10Y-43.8%-20.9%-22.9%

1.2. Operating Efficiency of Actinogen Medical Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Actinogen is operating .

  • Measures how much profit Actinogen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • An Operating Margin of -23,079.8% means the company generated $-230.80  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Actinogen Medical Ltd:

  • The MRQ is -23,079.8%. The company is operating very inefficient. -2
  • The TTM is -23,079.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-23,079.8%TTM-23,079.8%0.0%
TTM-23,079.8%YOY-14,369.7%-8,710.2%
TTM-23,079.8%5Y-12,297.5%-10,782.3%
5Y-12,297.5%10Y-9,673.6%-2,624.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-23,079.8%-313.9%-22,765.9%
TTM-23,079.8%-265.1%-22,814.7%
YOY-14,369.7%-331.0%-14,038.7%
5Y-12,297.5%-515.2%-11,782.3%
10Y-9,673.6%-609.4%-9,064.2%
1.2.2. Operating Ratio

Measures how efficient Actinogen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 320.76 means that the operating costs are $320.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 320.756. The company is inefficient in keeping operating costs low. -1
  • The TTM is 320.756. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ320.756TTM320.7560.000
TTM320.756YOY217.937+102.819
TTM320.7565Y183.307+137.448
5Y183.30710Y135.389+47.919
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ320.7563.013+317.743
TTM320.7563.644+317.112
YOY217.9374.501+213.436
5Y183.3076.353+176.954
10Y135.3898.330+127.059

1.3. Liquidity of Actinogen Medical Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Actinogen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 13.80 means the company has $13.80 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 13.799. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.799. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ13.799TTM13.7990.000
TTM13.799YOY19.940-6.141
TTM13.7995Y16.962-3.162
5Y16.96210Y17.037-0.075
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7994.571+9.228
TTM13.7995.011+8.788
YOY19.9406.142+13.798
5Y16.9626.306+10.656
10Y17.0376.588+10.449
1.3.2. Quick Ratio

Measures if Actinogen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • A Quick Ratio of 13.80 means the company can pay off $13.80 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 13.799. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.799. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ13.799TTM13.7990.000
TTM13.799YOY19.940-6.141
TTM13.7995Y16.805-3.006
5Y16.80510Y17.616-0.811
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7993.923+9.876
TTM13.7994.516+9.283
YOY19.9405.772+14.168
5Y16.8055.816+10.989
10Y17.6166.032+11.584

1.4. Solvency of Actinogen Medical Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Actinogen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Actinogen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.07 means that Actinogen assets are financed with 6.7% credit (debt) and the remaining percentage (100% - 6.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 0.067. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.067. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.067TTM0.0670.000
TTM0.067YOY0.050+0.017
TTM0.0675Y0.056+0.011
5Y0.05610Y0.078-0.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0670.311-0.244
TTM0.0670.298-0.231
YOY0.0500.269-0.219
5Y0.0560.377-0.321
10Y0.0780.409-0.331
1.4.2. Debt to Equity Ratio

Measures if Actinogen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Actinogen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 7.2% means that company has $0.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 0.072. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.072. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.072TTM0.0720.000
TTM0.072YOY0.053+0.019
TTM0.0725Y0.060+0.012
5Y0.06010Y0.093-0.033
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0720.362-0.290
TTM0.0720.361-0.289
YOY0.0530.277-0.224
5Y0.0600.425-0.365
10Y0.0930.460-0.367

2. Market Valuation of Actinogen Medical Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Actinogen generates.

  • Above 15 is considered overpriced but always compare Actinogen to the Biotechnology industry mean.
  • A PE ratio of -9.56 means the investor is paying $-9.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Actinogen Medical Ltd:

  • The EOD is -8.797. Company is losing money. -2
  • The MRQ is -9.562. Company is losing money. -2
  • The TTM is -9.562. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-8.797MRQ-9.562+0.765
MRQ-9.562TTM-9.5620.000
TTM-9.562YOY-60.309+50.747
TTM-9.5625Y-18.639+9.077
5Y-18.63910Y-67.458+48.819
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.797-6.313-2.484
MRQ-9.562-7.248-2.314
TTM-9.562-8.522-1.040
YOY-60.309-19.704-40.605
5Y-18.639-18.354-0.285
10Y-67.458-18.137-49.321
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Actinogen.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Actinogen Medical Ltd:

  • The MRQ is 22.454. Seems overpriced? -1
  • The TTM is 22.454. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ22.454TTM22.4540.000
TTM22.454YOY-47.655+70.108
TTM22.4545Y-66.449+88.903
5Y-66.44910Y-55.368-11.082
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ22.454-4.301+26.755
TTM22.454-6.130+28.584
YOY-47.655-13.925-33.730
5Y-66.449-12.463-53.986
10Y-55.368-11.860-43.508

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Actinogen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.18 means the investor is paying $4.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Actinogen Medical Ltd:

  • The EOD is 3.843. Neutral. Compare to industry.
  • The MRQ is 4.177. Neutral. Compare to industry.
  • The TTM is 4.177. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.843MRQ4.177-0.334
MRQ4.177TTM4.1770.000
TTM4.177YOY13.525-9.347
TTM4.1775Y5.517-1.339
5Y5.51710Y44.900-39.384
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.8431.808+2.035
MRQ4.1772.028+2.149
TTM4.1772.338+1.839
YOY13.5253.951+9.574
5Y5.5173.697+1.820
10Y44.9003.952+40.948
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Actinogen Medical Ltd.


4. Summary

4.1. Key Performance Indicators

The key performance indicators of Actinogen Medical Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0020.0020%0.004-35%0.001+73%0.001+100%
Book Value Growth--1.2451.2450%1.603-22%1.259-1%2.732-54%
Book Value Per Share--0.0120.0120%0.010+25%0.009+31%0.007+79%
Book Value Per Share Growth--1.2451.2450%1.603-22%1.259-1%2.732-54%
Current Ratio--13.79913.7990%19.940-31%16.962-19%17.037-19%
Debt To Asset Ratio--0.0670.0670%0.050+34%0.056+19%0.078-14%
Debt To Equity Ratio--0.0720.0720%0.053+37%0.060+20%0.093-23%
Dividend Per Share----0%-0%-0%-0%
Eps---0.005-0.0050%-0.002-59%-0.004-27%-0.003-50%
Eps Growth---0.426-0.4260%1.266-134%0.552-177%-0.390-8%
Free Cash Flow Per Share--0.0000.0000%0.000+111%-0.002+125481%-0.002+98296%
Free Cash Flow Per Share Growth--1.5251.5250%1.728-12%0.159+858%-0.288+119%
Free Cash Flow To Equity Per Share--0.0070.0070%0.006+23%0.003+134%0.002+308%
Free Cash Flow To Equity Per Share Growth--1.2291.2290%38.941-97%10.220-88%7.365-83%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.058-6%
Intrinsic Value_10Y_max--0.000--------
Intrinsic Value_10Y_min---0.013--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.002--------
Intrinsic Value_3Y_max--0.000--------
Intrinsic Value_3Y_min---0.004--------
Intrinsic Value_5Y_max--0.000--------
Intrinsic Value_5Y_min---0.007--------
Net Profit Margin---231.698-231.6980%-145.345-37%-126.013-46%-85.218-63%
Operating Margin---230.798-230.7980%-143.697-38%-122.975-47%-96.736-58%
Operating Ratio--320.756320.7560%217.937+47%183.307+75%135.389+137%
Pb Ratio3.843-9%4.1774.1770%13.525-69%5.517-24%44.900-91%
Pe Ratio-8.797+8%-9.562-9.5620%-60.309+531%-18.639+95%-67.458+605%
Peg Ratio--22.45422.4540%-47.655+312%-66.449+396%-55.368+347%
Price Per Share0.046-9%0.0500.0500%0.130-62%0.052-4%0.052-3%
Price To Total Gains Ratio19.512-9%21.20921.2090%35.940-41%9.686+119%-47.927+326%
Profit Growth---0.417-0.4170%1.265-133%0.543-177%-0.395-5%
Quick Ratio--13.79913.7990%19.940-31%16.805-18%17.616-22%
Return On Assets---0.408-0.4080%-0.214-48%-0.411+1%-0.394-3%
Return On Equity---0.438-0.4380%-0.226-48%-0.4360%-0.438+0%
Revenue Growth--1.5161.5160%0.288+426%0.887+71%1.830-17%
Total Gains Per Share--0.0020.0020%0.004-35%0.001+73%0.001+100%
Total Gains Per Share Growth--0.6520.6520%3.376-81%1.538-58%3.296-80%
Usd Book Value--14289621.15214289621.1520%11475196.641+25%10912352.623+31%7970604.436+79%
Usd Book Value Change Per Share--0.0020.0020%0.002-35%0.001+73%0.001+100%
Usd Book Value Per Share--0.0080.0080%0.006+25%0.006+31%0.004+79%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.0030%-0.001-59%-0.003-27%-0.002-50%
Usd Free Cash Flow---1930.490-1930.4900%-4067.372+111%-2424320.773+125481%-1899526.472+98296%
Usd Free Cash Flow Per Share--0.0000.0000%0.000+111%-0.001+125481%-0.001+98296%
Usd Free Cash Flow To Equity Per Share--0.0040.0040%0.004+23%0.002+134%0.001+308%
Usd Price Per Share0.030-9%0.0330.0330%0.085-62%0.034-4%0.034-3%
Usd Profit---6254767.548-6254767.5480%-2588043.161-59%-4654714.121-26%-3172644.203-49%
Usd Revenue--26995.31126995.3110%17806.257+52%44031.081-39%50495.824-47%
Usd Total Gains Per Share--0.0020.0020%0.002-35%0.001+73%0.001+100%
 EOD+2 -3MRQTTM+0 -0YOY+12 -275Y+18 -2110Y+19 -21

4.2. Fundamental Score

Let's check the fundamental score of Actinogen Medical Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.797
Price to Book Ratio (EOD)Between0-13.843
Net Profit Margin (MRQ)Greater than0-231.698
Operating Margin (MRQ)Greater than0-230.798
Quick Ratio (MRQ)Greater than113.799
Current Ratio (MRQ)Greater than113.799
Debt to Asset Ratio (MRQ)Less than10.067
Debt to Equity Ratio (MRQ)Less than10.072
Return on Equity (MRQ)Greater than0.15-0.438
Return on Assets (MRQ)Greater than0.05-0.408
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Actinogen Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.094
Ma 20Greater thanMa 500.054
Ma 50Greater thanMa 1000.061
Ma 100Greater thanMa 2000.073
OpenGreater thanClose0.047
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-06-302019-06-302020-06-302021-06-302022-06-30
Other Stockholders Equity  6,1286886,8166797,495-5,7591,736-3,940-2,204



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets23,306
Total Liabilities1,566
Total Stockholder Equity21,740
 As reported
Total Liabilities 1,566
Total Stockholder Equity+ 21,740
Total Assets = 23,306

Assets

Total Assets23,306
Total Current Assets20,417
Long-term Assets20,417
Total Current Assets
Cash And Cash Equivalents 16,370
Net Receivables 4,047
Total Current Assets  (as reported)20,417
Total Current Assets  (calculated)20,417
+/-0
Long-term Assets
Property Plant Equipment 169
Intangible Assets 2,720
Long-term Assets  (as reported)2,889
Long-term Assets  (calculated)2,889
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,480
Long-term Liabilities87
Total Stockholder Equity21,740
Total Current Liabilities
Short-term Debt 78
Accounts payable 899
Other Current Liabilities 502
Total Current Liabilities  (as reported)1,480
Total Current Liabilities  (calculated)1,480
+/-0
Long-term Liabilities
Long term Debt Total 87
Long-term Liabilities  (as reported)87
Long-term Liabilities  (calculated)87
+/- 0
Total Stockholder Equity
Common Stock76,943
Retained Earnings -57,939
Accumulated Other Comprehensive Income 2,736
Total Stockholder Equity (as reported)21,740
Total Stockholder Equity (calculated)21,740
+/-0
Other
Capital Stock76,943
Cash And Equivalents12,100
Cash and Short Term Investments 16,370
Common Stock Shares Outstanding 1,717,092
Liabilities and Stockholders Equity 23,306
Net Debt -16,205
Net Invested Capital 21,740
Net Tangible Assets 19,019
Net Working Capital 18,937
Short Long Term Debt Total 165



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
> Total Assets 
53
268
2,942
2,008
1,342
1,141
466
276
1,262
15,579
12,950
10,210
18,026
16,222
11,936
18,378
23,306
23,30618,37811,93616,22218,02610,21012,95015,5791,2622764661,1411,3422,0082,94226853
   > Total Current Assets 
0
0
2,598
1,861
1,119
907
286
138
1,154
10,021
7,744
5,364
13,536
12,527
8,164
15,056
20,417
20,41715,0568,16412,52713,5365,3647,74410,0211,1541382869071,1191,8612,59800
       Cash And Cash Equivalents 
44
48
2,541
1,850
1,085
861
204
113
1,128
9,806
752
1,895
10,004
7,637
5,040
13,422
16,370
16,37013,4225,0407,63710,0041,8957529,8061,1281132048611,0851,8502,5414844
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
4,026
2,095
0
0
0
0
0
000002,0954,0260000000000
       Net Receivables 
2
50
54
10
33
30
23
4
11
182
2,929
1,342
3,485
4,833
2,662
1,634
4,047
4,0471,6342,6624,8333,4851,3422,9291821142330331054502
       Other Current Assets 
0
164
3
1
2
15
59
21
15
34
38
33
47
57
461
0
0
004615747333834152159152131640
   > Long-term Assets 
0
0
343
147
223
234
180
138
108
5,558
5,205
4,846
4,490
3,695
3,772
3,322
2,889
2,8893,3223,7723,6954,4904,8465,2055,55810813818023422314734300
       Property Plant Equipment 
7
6
13
106
148
144
137
120
107
7
8
2
0
0
391
254
169
169254391002871071201371441481061367
       Long Term Investments 
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
00000000200000000
       Intangible Assets 
0
0
0
16
16
16
16
16
0
5,551
5,197
4,843
4,490
3,660
3,346
3,033
2,720
2,7203,0333,3463,6604,4904,8435,1975,55101616161616000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
107
35
35
35
0
0353535107000000000000
> Total Liabilities 
29
60
82
105
174
95
119
81
50
223
824
844
768
557
1,048
920
1,566
1,5669201,048557768844824223508111995174105826029
   > Total Current Liabilities 
29
60
82
105
174
95
119
81
50
223
824
844
768
557
744
755
1,480
1,480755744557768844824223508111995174105826029
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
4,026
2,095
0
0
86
71
78
787186002,0954,0260000000000
       Accounts payable 
0
0
11
14
23
29
9
10
9
192
690
649
507
283
47
392
899
8993924728350764969019291092923141100
       Other Current Liabilities 
29
39
72
91
151
66
110
71
41
30
134
195
261
275
611
292
502
5022926112752611951343041711106615191723929
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
283
304
165
87
871653042830000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
304
165
87
8716530400000000000000
> Total Stockholder Equity
24
208
2,859
1,902
1,168
1,046
347
194
1,212
15,357
12,125
9,366
17,258
15,665
10,889
17,458
21,740
21,74017,45810,88915,66517,2589,36612,12515,3571,2121943471,0461,1681,9022,85920824
   Retained Earnings -57,939-48,442-44,527-39,196-29,309-23,078-19,888-16,254-10,823-10,383-10,218-8,689-7,947-7,209-6,28200
   Accumulated Other Comprehensive Income 
0
0
4,819
4,789
4,792
4,815
4,789
4,789
4,789
5,356
5,705
5,865
6,128
6,816
7,491
5,846
2,736
2,7365,8467,4916,8166,1285,8655,7055,3564,7894,7894,7894,8154,7924,7894,81900
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2022-06-30)

Gross Profit (+$)
totalRevenue41
Cost of Revenue--
Gross Profit-41
 
Operating Income (+$)
Gross Profit-
Operating Expense-13,173
Operating Income-9,479-13,173
 
Operating Expense (+$)
Research Development8,215
Selling General Administrative4,558
Selling And Marketing Expenses-
Operating Expense13,17312,773
 
Net Interest Income (+$)
Interest Income41
Interest Expense-18
Other Finance Cost-0
Net Interest Income23
 
Pretax Income (+$)
Operating Income-9,479
Net Interest Income23
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-9,497-9,460
EBIT - interestExpense = -9,497
-9,497
-9,497
Interest Expense18
Earnings Before Interest and Taxes (EBIT)-9,479-9,479
Earnings Before Interest and Taxes (EBITDA)-9,078
 
After tax Income (+$)
Income Before Tax-9,497
Tax Provision-0
Net Income From Continuing Ops-9,497-9,497
Net Income-9,516
Net Income Applicable To Common Shares-9,497
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses13,173
Total Other Income/Expenses Net-18-23
 

Technicals of Actinogen

1. Trend Indicators

1.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Actinogen Medical Ltd Daily Moving Averages ChartActinogen Medical Ltd Daily Moving Averages Chart
1.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Let's take a look of the Moving Average Convergence/Divergence (MACD) of Actinogen Medical Ltd:

  • The Moving Average Convergence/Divergence (MACD) is -0.005. The Moving Average Convergence/Divergence (MACD) below zero is a bearish sign. -1
  • The MACD is lower than the signal line. This is a bearish indication. -1
Actinogen Medical Ltd Daily Moving Average Convergence/Divergence (MACD) ChartActinogen Medical Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
1.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index).

The ADX helps you determine the strength of a trend. Let's take a look of the ADX of Actinogen Medical Ltd:

  • The ADX is 24.471. Absent or Weak Trend. -1
  • The ADX is rising, a new trend could be forming. +1
  • The +DI is lower than the -DI. The current trend is down. -2
Actinogen Medical Ltd Daily Directional Movement Index (DMI) ChartActinogen Medical Ltd Daily Directional Movement Index (DMI) Chart
1.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..
  • The Parabolic SAR is higher than the price. The current trend is down. -2
  • Actinogen Medical Ltd Daily Parabolic SAR ChartActinogen Medical Ltd Daily Parabolic SAR Chart

    2. Momentum Indicators

    2.1 Relative Strength Index (RSI)

    Measures the speed and change of price movements.

    • Leading momentum indicator, meaning the signals are instant.
    • Ranges between 0 and 100.
    • Above 70 is considered overbought.
    • Below 30 is considered oversold.
    • Above or below 50 can also be used to determine price trend or support and resistance.
    • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
    • Can be used in many different ways
    • The RSI is below 50. -1
    Actinogen Medical Ltd Daily Relative Strength Index (RSI) ChartActinogen Medical Ltd Daily Relative Strength Index (RSI) Chart
    2.2 Stochastic Oscillator

    Compares a certain price to multiple prices ranging over time.

    • Leading momentum indicator, meaning the signals are instant.
    • Used to determine overbought and oversold areas much like the RSI.
    • Ranges between 0 and 100.
    • Above 80 is considered overbought.
    • Below 20 is considered oversold.
    • Consists of two lines named K and D.
    • K compares the highest high and lowest low on the selected price range.
    • The D line is a moving average of the K line.
    • Can be used to spot divergences
    • The Stochastic is below 50. -1
    • The Stochastic is below 30 and oversold. +2
    Actinogen Medical Ltd Daily Stochastic Oscillator ChartActinogen Medical Ltd Daily Stochastic Oscillator Chart
    2.3 Commodity Channel Index (CCI)
    Actinogen Medical Ltd Daily Commodity Channel Index (CCI) ChartActinogen Medical Ltd Daily Commodity Channel Index (CCI) Chart
    2.4 Chande Momentum Oscillator (CMO)
    Actinogen Medical Ltd Daily Chande Momentum Oscillator (CMO) ChartActinogen Medical Ltd Daily Chande Momentum Oscillator (CMO) Chart
    2.5 Williams %R
    Actinogen Medical Ltd Daily Williams %R ChartActinogen Medical Ltd Daily Williams %R Chart

    3. Volatility Indicators

    3.1 Bollinger Bands
    Actinogen Medical Ltd Daily Bollinger Bands ChartActinogen Medical Ltd Daily Bollinger Bands Chart
    3.2 Average True Range (ATR)
    Actinogen Medical Ltd Daily Average True Range (ATR) ChartActinogen Medical Ltd Daily Average True Range (ATR) Chart

    4. Volume Indicators

    4.1 On-Balance Volume (OBV)
    Actinogen Medical Ltd Daily On-Balance Volume (OBV) ChartActinogen Medical Ltd Daily On-Balance Volume (OBV) Chart
    4.2 Money Flow Index (MFI)
    Actinogen Medical Ltd Daily Money Flow Index (MFI) ChartActinogen Medical Ltd Daily Money Flow Index (MFI) Chart

    5. Summary

    5.1. Notifications

    TypeNotificationDate
    PenkeCurrently no notifications for Actinogen Medical Ltd.

    5.2. Trading Signals

    DateIndicatorEntry signalExit signal
    2023-05-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
    WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
    2023-05-23STOCH LONG ENTRY SHORT CLOSE20 crossover to upside
    ATR LONG ENTRY SHORT CLOSE

    5.2. Technical Score

    Let's check the technical score of Actinogen Medical Ltd based on Penke's default Symbol scanner.

    Penke's Symbol Scanner

      
      
    IndicatorConditionValue
    RsiGreater than5030.094
    Ma 20Greater thanMa 500.054
    Ma 50Greater thanMa 1000.061
    Ma 100Greater thanMa 2000.073
    OpenGreater thanClose0.047
    Total1/5 (20.0%)

    Comments

    Join the conversation.

    Leave a comment

    Stay informed about Actinogen Medical Ltd.

    Receive notifications about Actinogen Medical Ltd in your mailbox!

    Penke's Market Notifications
    IXIC.INDX
    now

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of IXIC.INDX.

    IXIC.INDX Daily Candlestick Chart
    PRAU.XETRA
    now

    I found you a Golden Cross on the daily chart of PRAU.XETRA.

    PRAU.XETRA Daily Candlestick Chart
    PRAB.XETRA
    now

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of PRAB.XETRA.

    PRAB.XETRA Daily Candlestick Chart
    P500.XETRA
    2 minutes ago

    I found you a Golden Cross on the daily chart of P500.XETRA.

    P500.XETRA Daily Candlestick Chart
    AVVA.INDX
    9 minutes ago

    I found you a STOCH Bearish Hidden Divergence on the daily chart of AVVA.INDX.

    AVVA.INDX Daily Candlestick Chart
    DJU.INDX
    9 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of DJU.INDX.

    DJU.INDX Daily Candlestick Chart
    ADVN.INDX
    9 minutes ago

    I found you a MACD Bearish Reversal Divergence on the daily chart of ADVN.INDX.

    ADVN.INDX Daily Candlestick Chart
    SPFU.XETRA
    44 minutes ago

    I found you a Golden Cross on the daily chart of SPFU.XETRA.

    SPFU.XETRA Daily Candlestick Chart
    XMLC.XETRA
    50 minutes ago

    I found you a Golden Cross on the daily chart of XMLC.XETRA.

    XMLC.XETRA Daily Candlestick Chart
    JCHE.XETRA
    51 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of JCHE.XETRA.

    JCHE.XETRA Daily Candlestick Chart
    NK4L.XETRA
    51 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of NK4L.XETRA.

    NK4L.XETRA Daily Candlestick Chart
    METV.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of METV.XETRA.

    METV.XETRA Daily Candlestick Chart
    KTN.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of KTN.XETRA.

    KTN.XETRA Daily Candlestick Chart
    ECMS.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of ECMS.XETRA.

    ECMS.XETRA Daily Candlestick Chart
    XDPU.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of XDPU.XETRA.

    XDPU.XETRA Daily Candlestick Chart
    JCGA.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of JCGA.LSE.

    JCGA.LSE Daily Candlestick Chart
    JCAS.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of JCAS.LSE.

    JCAS.LSE Daily Candlestick Chart
    JCAP.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of JCAP.LSE.

    JCAP.LSE Daily Candlestick Chart
    SZU.XETRA
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of SZU.XETRA.

    SZU.XETRA Daily Candlestick Chart
    EQQD.LSE
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of EQQD.LSE.

    EQQD.LSE Daily Candlestick Chart
    H4ZN.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of H4ZN.XETRA.

    H4ZN.XETRA Daily Candlestick Chart
    CBUN.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of CBUN.XETRA.

    CBUN.XETRA Daily Candlestick Chart
    DRGG.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of DRGG.LSE.

    DRGG.LSE Daily Candlestick Chart
    I500.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of I500.XETRA.

    I500.XETRA Daily Candlestick Chart
    FUSR.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of FUSR.XETRA.

    FUSR.XETRA Daily Candlestick Chart